M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Medicofarma Biotech SA

Current Assets 2.9m
Cash & Short-Term Investments 59.9k
Receivables 464.8k
Other Current Assets 2.4m
Non-Current Assets 12.7m
PP&E 11.7m
Intangibles 958.2k
Other Non-Current Assets -10
Current Liabilities 3.6m
Accounts Payable 2.2m
Accrued Liabilities 1.3m
Other Current Liabilities 182k
Non-Current Liabilities 2.1m
Other Non-Current Liabilities 2.1m

Balance Sheet
Medicofarma Biotech SA

Rotate your device to view
Balance Sheet
Currency: PLN
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
0
0
0
0
0
0
0
1
Cash
0
0
0
0
0
0
0
1
Short-Term Investments
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
1
1
0
1
1
Accounts Receivables
0
0
0
0
0
0
1
0
Other Receivables
0
0
0
1
1
0
0
0
Inventory
0
0
0
0
0
0
1
0
Other Current Assets
0
0
0
0
0
0
0
1
Total Current Assets
1
1
1
1
1
0
2
2
PP&E Net
0
0
0
0
0
0
13
13
Intangible Assets
0
0
0
0
0
0
2
2
Note Receivable
0
1
1
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
Total Assets
1
N/A
2
+5%
2
+13%
2
-7%
1
-15%
0
-71%
17
+4 093%
16
-2%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
1
Accrued Liabilities
0
0
0
0
0
0
0
1
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
1
Total Current Liabilities
1
0
1
1
1
1
1
3
Long-Term Debt
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
2
0
Total Liabilities
1
N/A
1
+11%
1
+24%
1
-22%
1
+15%
1
-11%
3
+313%
4
+47%
Equity
Common Stock
1
1
1
1
1
1
7
7
Retained Earnings
0
0
0
0
0
1
2
3
Additional Paid In Capital
0
0
0
0
0
0
9
9
Total Equity
1
N/A
1
+2%
1
+5%
1
+5%
1
-33%
0
N/A
14
N/A
13
-11%
Total Liabilities & Equity
1
N/A
2
+5%
2
+13%
2
-7%
1
-15%
0
-71%
17
+4 093%
16
-2%
Shares Outstanding
Common Shares Outstanding
7
7
7
7
7
7
68
68

See Also

Discover More